Literature DB >> 2465064

Localization of substance P and neurofilament immunoreactive fibers in the lumbar facet joint capsule and supraspinous ligament of the rabbit.

A el-Bohy1, J M Cavanaugh, M L Getchell, T Bulas, T V Getchell, A I King.   

Abstract

An indirect immunofluorescence method was utilized to identify substance P-like immunoreactive (SPLI) and neurofilament protein immunoreactive (NFIR) fibers in the lumbar facet joint capsule and supraspinous ligament of the rabbit. The results demonstrated a large population of NFIR fibers, indicating that these tissues are richly innervated, and a smaller population of SPLI fibers. In some fibers, neurofilament protein and substance P were colocalized. The data suggest that the facet joint capsule and the supraspinous ligament contain SPLI nociceptive fibers that could be a source of low back pain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2465064     DOI: 10.1016/0006-8993(88)90386-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  The spatiotemporal development of innervation in spinal ligaments of chickens.

Authors:  H Jiang; M Moreau; N Greidanus; J Bilo; G Russell; J Raso; K Bagnall
Journal:  J Anat       Date:  1996-08       Impact factor: 2.610

2.  Encapsulated Ruffini-like endings in human lumbar facet joints.

Authors:  F Vandenabeele; J Creemers; I Lambrichts; P Lippens; M Jans
Journal:  J Anat       Date:  1997-11       Impact factor: 2.610

3.  Number, distribution and neuropeptide content of rat knee joint afferents.

Authors:  P T Salo; E Theriault
Journal:  J Anat       Date:  1997-05       Impact factor: 2.610

4.  Mechanoreceptor endings of the cervical, thoracic, and lumbar spine.

Authors:  R F McLain; K Raiszadeh
Journal:  Iowa Orthop J       Date:  1995

5.  Mechanoreceptor endings in human cervical facet joints.

Authors:  R F McLain
Journal:  Iowa Orthop J       Date:  1993

6.  Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial.

Authors:  Xuejiao Guo; Lin Li; Zhe Yan; Yunze Li; Zhiyou Peng; Yixin Yang; Yanfeng Zhang; Christoph Schmitz; Zhiying Feng
Journal:  J Orthop Surg Res       Date:  2021-12-04       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.